Andrew J. Cutler, MD: The Impact of Screen Time on ADHD

Video

A large portion of communication is non-verbal.

While screening and diagnostic techniques for attention deficit/ hyperactivity disorder (ADHD) have not changed much in recent decades, the growing reliance on new technology may be making it more challenging.

In an interview with HCPLive®, Andrew J. Cutler, MD, Clinical Professor of Psychiatry at SUNY Upstate Medical University, explained how more screen time for all adolescents is making the diagnostic process for ADHD more challenging.

Cutler explained that the time adolescents and adults spend using cell phones and tablets has increased in recent years, making it more difficult for some doctors to diagnose the disorder because a large portion of conversations are non-verbal.

“Something very significant is lost in our ability to pick up verbal cues—facial expressions, mannerisms,” Cutler said. “In general, it has made it harder to make the diagnosis.”

However, it could be helpful for some patients more comfortable with virtual technology and less comfortable with one-on-one interactions.

Cutler also said with more people working from home and students doing virtual schooling, screen time might begin to drastically increase. He also said there is some concerns with less in-person therapy sessions that patients will forgo their treatments more commonly and fill less prescriptions.

At the annual Neuroscience Education Institute Max! Virtual meeting, Cutler will present multiple times about ADHD and other psychiatric disorders.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.